Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Ono scientists present new CB2 receptor agonists

March 27, 2002

Sequella Global Tuberculosis Foundation collaborates to develop new TB vaccines

March 27, 2002

Encouraging phase I results reported for StreptAvax vaccine

March 25, 2002

Isotechnika enters negotiations for drug development agreement

March 25, 2002

Research at Corixa leads to new hepatitis B and influenza vaccines

March 22, 2002

Vaccine for West Nile virus highly effective in mice, slated for clinical trials this year

March 21, 2002

Sankyo describes novel immunosuppressants in a recent patent

March 20, 2002

Comparative study of Thymoglobulin and Simulect in kidney transplant rejection closed early

March 19, 2002

Deltagen's drug target DT021I enters development program for inflammatory diseases

March 18, 2002

Phase I results show Product R to be safe and well tolerated

March 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...